These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29683741)

  • 21. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients.
    Bertoglio S; Solari N; Meszaros P; Vassallo F; Bonvento M; Pastorino S; Bruzzi P
    Cancer Nurs; 2012; 35(4):E35-42. PubMed ID: 22228390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
    Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
    J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.
    Royle TJ; Davies RE; Gannon MX
    Ann R Coll Surg Engl; 2008 Nov; 90(8):679-84. PubMed ID: 18990281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.
    Solinas G; Platini F; Trivellato M; Rigo C; Alabiso O; Galetto AS
    J Vasc Access; 2017 Jul; 18(4):325-327. PubMed ID: 28665463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
    Burbridge B; Goyal K
    J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difficult removal of totally implantable venous access devices in adult patients: Incidence, risk factors, and management.
    Chatani S; Tsukii R; Nagasawa K; Hasegawa T; Murata S; Kato M; Yamaura H; Onaya H; Matsuo K; Watanabe Y; Inaba Y
    J Vasc Access; 2023 Sep; 24(5):1150-1157. PubMed ID: 35081814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on totally implantable venous access devices.
    Zaghal A; Khalife M; Mukherji D; El Majzoub N; Shamseddine A; Hoballah J; Marangoni G; Faraj W
    Surg Oncol; 2012 Sep; 21(3):207-15. PubMed ID: 22425356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
    Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
    G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chinese expert consensus on the nursing management of the totally implantable venous access device.
    Xu Y; Fei XY; Xue YH; Wang XM; Wang XY; Zheng YT; Chen K; He JJ; Ren XH; Pan L; Wang L; Qian D; Li WF; Liang Y; Fang Y; Huang XF; Li CH; Chen DP; Wang Y; Wen LH; Zhang YH; Zheng Y; Song H; Lin YC; Zhang Q; Yang RM; Wang ZM
    J Cancer Res Ther; 2022 Sep; 18(5):1231-1240. PubMed ID: 36204867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there any effect of first-day usage of a totally implantable venous access device on complications?
    Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
    Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central Venous Catheter Flushing Recommendations: A Systematic Evidence-Based Practice Review.
    Conway MA; McCollom C; Bannon C
    J Pediatr Oncol Nurs; 2014 Jul; 31(4):185-190. PubMed ID: 24794887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A change in flushing protocols of central venous catheters.
    Kelly C; Dumenko L; McGregor SE; McHutchion ME
    Oncol Nurs Forum; 1992 May; 19(4):599-605. PubMed ID: 1603675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report: Extravascular catheter migration in a child: A rare complication of the totally implantable venous access device.
    Lu X; Ren Y; Wan H; Xu Q; Duan S
    Medicine (Baltimore); 2023 Feb; 102(8):e32710. PubMed ID: 36827053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
    Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
    Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary to: Goossens, G.A., Stas, M., Moons, P., 2012. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. European Journal of Oncology Nursing 16 (5), 465-471.
    Hance SN; Glenn LL
    Eur J Oncol Nurs; 2012 Dec; 16(5):472. PubMed ID: 22884874
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients.
    Burbridge B; Plewes C; Stoneham G; Szkup P; Otani R; Babyn P; Bryce R
    J Vasc Interv Radiol; 2018 May; 29(5):648-656.e3. PubMed ID: 29499999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.